Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.
about
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsThe antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosisUse of Antibiotics in Pediatrics: 8-Years Survey in Italian HospitalsPreclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis.Moxifloxacin safety: an analysis of 14 years of clinical data.In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline.Clarithromycin extended-release in community-acquired respiratory tract infections.Update on the cardiac safety of moxifloxacin.Evaluation of a sex-based difference in the pharmacokinetics of digoxin.Current perspectives on management of co-morbid depression in COPD.Role of macrolide therapy in chronic obstructive pulmonary disease.Clinical and economic evaluation of gatifloxacin and levofloxacin.The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms.Ketolides in the treatment of community-acquired respiratory tract infections: A review.Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.Observations on conducting whole-cell patch clamping of the hERG cardiac K+ channel in pure human serum.Life-threatening cardiac arrhythmias due to drug-induced QT prolongation : A retrospective study over 6 years from a medical intensive care unit.The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspectiveand Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation
P2860
Q28072205-EC48517F-64C6-40CE-A240-421777B568A7Q28475461-7A68E8EA-5C7F-4F27-B3A9-8545759E5B21Q28548548-2D0FE692-76BD-476A-8C50-A7E1D216F5B0Q33586699-B7388B7C-9AF9-46EA-820D-6570BC43BD8FQ34310568-A8FC13BE-E023-4BDF-B27D-26CED02B00B8Q34531473-CA79F348-68F5-4456-A979-6C77DA621CA9Q36327107-85F9A1D7-0666-4CF9-B931-63A658D2602CQ36345861-039B8136-5668-46D4-B05B-CCC64FDB17F5Q36410175-8D673FD9-58F8-48D6-884F-49DF984CF133Q36669469-0A997348-A1C5-49DA-8732-D4BF631BFD36Q37319950-B6D2035D-9762-4D0B-8B55-B4529E1BE0E8Q37609183-D4360B31-FD6D-4D09-938D-5CEDEF7EEACBQ37954711-6A2F282B-9B39-4281-8E16-F75A0418F80CQ38199663-7BEAD5D6-7FCB-4567-BCB3-8665BB9BF391Q40108685-A15C5757-3F85-4148-B046-AD90533E7747Q40317287-4033FC27-67AE-4B28-9120-EF4FBC4619CAQ48017483-FC4416D1-B80E-453E-98CC-0286DBAE5353Q53361310-DB1584E4-40FC-4A77-8CE9-04E6F5122845Q56855345-21E29E40-5E02-448A-8C0D-A6635ECD0DC5Q58700580-3B51CBB2-5584-4B07-8F83-74C4FAF6372C
P2860
Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@ast
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@en
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@nl
type
label
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@ast
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@en
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@nl
prefLabel
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@ast
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@en
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@nl
P2860
P356
P1476
Cardiotoxicity of macrolides, ...... that prolong the QTc interval.
@en
P2093
Paul B Iannini
P2860
P304
P356
10.1517/14740338.1.2.121
P407
P577
2002-07-01T00:00:00Z